Viking Therapeutics, Inc.
Clinical trials sponsored by Viking Therapeutics, Inc., explained in plain language.
-
New daily pill shows promise for weight loss in phase 2 trial
Disease control CompletedThis study tested an experimental daily pill, VK2735, to help adults with obesity or overweight (plus a weight-related health issue) lose weight. About 280 participants took either the pill or a placebo for 13 weeks. The main goal was to see how much weight they lost and if the p…
Phase: PHASE2 • Sponsor: Viking Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 07:54 UTC
-
New drug aims to speed up hip fracture recovery in seniors
Symptom relief CompletedThis study tested an experimental drug called VK5211 in 108 older adults (65+) who had recently broken a hip. The goal was to see if the drug could help rebuild muscle and improve recovery compared to a placebo. Participants took the drug or a dummy pill for 12 weeks, and researc…
Phase: PHASE2 • Sponsor: Viking Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 07:57 UTC